Search...
/
The Fly Cast
Press play to listen
Smarter market moves start here
Competitive Advantages
Global Scale and Reach: Icon is one of the largest CROs globally, offering extensive geographical reach and the capacity to manage complex, multi-country clinical trials efficiently, which is highly attractive to large pharmaceutical and biotech clients.
Integrated Service Offering: The company provides a comprehensive suite of clinical research services across the entire drug development lifecycle, from early phase to post-approval, including lab services, imaging, and consulting, simplifying vendor management and ensuring seamless project execution for clients.
Deep Therapeutic Area Expertise: Icon possesses specialized knowledge and experience across a broad range of therapeutic areas, particularly in high-growth and complex fields like oncology, rare diseases, and central nervous system disorders, enhancing trial design and execution quality.
Risks
Reliance on Client R&D Investment: Icon's revenue is heavily dependent on the research and development spending of pharmaceutical and biotechnology companies, which can fluctuate with market conditions and funding availability.
Intense Market Competition: The contract research organization (CRO) market is highly competitive, leading to potential pricing pressures, loss of market share, or difficulty securing new contracts.
Evolving Regulatory Landscape: Changes in global pharmaceutical and medical device regulations can increase compliance costs, delay clinical trials, or require significant operational adjustments.
Yesterday
Yesterday, 4:50 AM
Tuesday
Jun 23, 4:17 PM
Jun 23, 4:16 PM
Jun 23, 1:34 PM
Over a week ago
Jun 8, 1:49 PM
Jun 1, 7:51 AM
Jun 1, 6:35 AM
May 29, 9:59 AM
May 29, 9:18 AM
May 29, 8:42 AM
May 29, 7:42 AM
May 29, 7:39 AM
May 29, 6:40 AM
May 29, 6:24 AM
May 29, 5:03 AM
May 28, 1:28 PM
May 27, 4:39 PM
May 27, 4:36 PM
May 27, 3:43 PM
May 27, 8:06 AM
May 20, 2:49 PM